Damian Sousa »

Krystal Biotech shares owned by Damian Sousa

Quarter-by-quarter ownership of Krystal Biotech (KRYS) shares owned by Damian Sousa from 13F filings

Historical chart of Damian Sousa investment in Krystal Biotech

Tip: Access up to 7 years of quarterly data

All positions including Krystal Biotech held by Damian Sousa consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Krystal Biotech by Damian Sousa

Quarter filed Position value Share count Share price at filing
2024-09-30 $13M 64k 199.61
2024-06-30 $14M 76k 182.27

More positions owned by Damian Sousa

Accenture Plc-cl A Common Stock
Microsoft Corp Common Stock (MSFT)
Broadcom Common Stock (AVGO)
Jpmorgan Chase & Co Common Stock (JPM)
Cencora Common Stock (COR)
Rb Global Common Stock (RBA)
Baker Hughes Common Stock (BKR)
Ares Management Corp - A Common Stock (ARES)
Goldman Sachs Group Common Stock (GS)
Wabtec Corp Common Stock (WAB)
Axon Enterprise Common Stock (AXON)
Eaton Corp Common Stock (ETN)
Pnc Financial Services Group Common Stock (PNC)
Chevron Corp Common Stock (CVX)
Royal Caribbean Cruises Common Stock (RCL)

View all positions for Damian Sousa

Top funds holding Krystal Biotech

FMR
BlackRock
Vanguard Group
venBio Select Advisor
State Street Corporation
Soleus Capital Management
Capital World Investors
Frazier Life Sciences Management
Citadel Advisors
Redmile Group
Geode Capital Management
Hood River Capital Management
Dimensional Fund Advisors
Braidwell
Goldman Sachs Group

View all funds holding Krystal Biotech